Abstract

The Agile BioFoundry (ABF) is a multi-national lab consortium funded by the Department of Energy’s Bioenergy Technologies Office that has developed a biofoundry that enables the rapid deployment of bioproducts into the market. Working with two ABF laboratory members (National Renewable Energy Laboratory (NREL) and Pacific Northwest National Laboratory (PNNL), Danimer will develop bacterial strains to produce PHAs with different compositions aimed at expanding Danimer’s product offerings. This project will enable the ABF to contribute to the development of a high-profile, commercial product that falls squarely in the DOE mission space and has strong potential to have meaningful benefit both to the US economy and the environment.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.